Zurueck zur Suche

Reporte zur Charge U008181

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

15Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
GA 3 OK 3 AL 3 FL 2 TX 2 MO 1 NY 1

VAERS 2020717

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge u008181

schwer
Staat
MO
Alter
1,0
Geschlecht
M
Eingang
10.01.2022
Impfdatum
06.01.2022
Beginn
07.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Ear infection Pyrexia Seizure

Symptomtext

Seizure started about 3:30 pm day after vaccination didn't stop until EMS arrived and gave medication at about 3:50. was air lift to hospital. Only had 1 seizure. took a long time to wake up and come back to baseline. Had fever following but did not have more seizures.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
no follow up test were done at this time.
Aktuelle Erkrankungen
ear infection dx day after vaccinations
Vorgeschichte
-
Andere Medikamente
Zyrtec , Elsberry supplement
Allergien
nka
Vorherige Impfungen
-

VAERS 2010028

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

mild
Staat
GA
Alter
19,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
06.01.2022
Beginn
06.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Feeling hot Lip swelling Pruritus Rash

Symptomtext

Patient reported itching, felt hot, presented with axillary rash, redness to face and head, swelling of lips

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE REPORTED
Vorgeschichte
NONE REPORTED
Andere Medikamente
NONE REPORTED
Allergien
NO KNOWN DRUG ALLERGIES
Vorherige Impfungen
-

VAERS 1906096

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

mild
Staat
OK
Alter
2,0
Geschlecht
M
Eingang
29.11.2021
Impfdatum
19.11.2021
Beginn
20.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Urticaria

Symptomtext

Breakout of hives all over affected area and tactile fever the next day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Patient reported to Dr. for concerns over the possible reaction to vaccines. Advised parent that fever is normal for up to 3 days after vaccines. Although hives are an abnormal reaction, the closer the reaction of the disease (MMR) then the more prominent the coverage against the disease.
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Cetirizine 5ml QD Hydrocortisone 2.5% cream
Allergien
N/A
Vorherige Impfungen
-

VAERS 1873801

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

mild
Staat
AL
Alter
4,0
Geschlecht
F
Eingang
16.11.2021
Impfdatum
10.11.2021
Beginn
12.11.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site reaction Injection site swelling Injection site warmth Pallor

Symptomtext

Left anterior thigh with blanching erythema approx. 8 x 10 cm, warm/ slight swelling, non-tender. Right anterior thigh with approx. 1-2 cm area of redness around injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1809826

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

mild
Staat
FL
Alter
1,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
19.10.2021
Beginn
20.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Eczema Pyrexia Rash Rash maculo-papular

Symptomtext

12 month vaccines given 10/19/2021. Parent called 10/22/21 due to concerns with a rash and low grade fever 100.4 to torso 10/19/21 after vaccines. no swelling at injection site, rash did not appear painful or itchy. maculopapular rash to torso. scattered dry patches (history of eczema) supportive care given and to monitor for worsening signs or symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
history of atopic dermatitis
Andere Medikamente
hydrocortisone cream
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2449442

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
AL
Alter
-
Geschlecht
F
Eingang
17.09.2022
Impfdatum
19.07.2022
Beginn
19.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details; 1 lot of VARIVAX was administered after non-supported excursion; This spontaneous report has been received from an office manager, regarding an unspecified number of patients of unknown gender and age. Information regarding the patients' historical conditions, past drugs reactions or allergies, concurrent conditions or concomitant therapies was not provided. On 19-JUL-2022, the varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U008181, expiration date: 16-JUN-2022 experienced 08-FEB-2023) was administered after non-supported excursion (product storage error). Temperature excursion of 10.2 Celsius degrees (C) for 182 hour. No additional adverse events (AE) reported (no adverse event). This case was classified as non-valid due to the lack of patient's identifiers. Follow-up was received from the office manager on 09-SEP-2022. It was updated, that not properly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) was administered to 16-year old female patient, and her sister. There was reported, that temperatures were misread and misrecorded, and that is why the medication error occurred. It was confirmed, that no adverse reactions were reported.; Sender's Comments: US-009507513-2207USA008558:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2449367

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
AL
Alter
-
Geschlecht
F
Eingang
17.09.2022
Impfdatum
19.07.2022
Beginn
19.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Medication error No adverse event Product storage error

Symptomtext

No additional AE details; 1 lot of VARIVAX was administered after non-supported excursion; This spontaneous report has been received from an office manager, regarding an unspecified number of patients of unknown gender and age. Information regarding the patients' historical conditions, past drugs reactions or allergies, concurrent conditions or concomitant therapies was not provided. On 19-JUL-2022, the varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U008181, expiration date: 16-JUN-2022 experienced 08-FEB-2023) was administered after non-supported excursion (product storage error). Temperature excursion of 10.2 Celsius degrees (C) for 182 hour. No additional adverse events (AE) reported (no adverse event). This case was classified as non-valid due to the lack of patient's identifiers. Follow-up was received from the office manager on 09-SEP-2022. It was updated, that not properly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) was administered to 4-year old female patient, and her sister. There was reported, that temperatures were misread and misrecorded, and that is why the medication error occurred. It was confirmed, that no adverse reactions were reported. This is one from two reports from the same reporter.; Sender's Comments: US-009507513-2209USA004279:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2338749

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
OK
Alter
1,1
Geschlecht
M
Eingang
28.06.2022
Impfdatum
21.06.2022
Beginn
21.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Patient was given vaccine after temperature excursion , vaccines exposed to above range temperatures

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2325346

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
GA
Alter
1,4
Geschlecht
M
Eingang
21.06.2022
Impfdatum
09.06.2022
Beginn
17.06.2022
Tage bis Beginn
8,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Induration Peripheral swelling Tenderness

Symptomtext

Left thigh with 2-3cm x 1-2cm erythematous and slightly swollen - with some mild firmness and tender to touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hearing loss , microtia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2254041

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
27.04.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE's and no PQC's were reported.; A medical assistant reported that an improperly stored vaccine was administered to a patient.; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported. On 11-APR-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot number U008181 has been determined to be valid for varicella virus vaccine live (oka/merck), expiration date reported and established as 08-FEB-2023) (strength, dose, frequency, route of administration and anatomical location were not provided). No adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2225591

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
11.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Patient was administered improperly stored VARIVAX at 8:30 AM on 04/04/2022; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 04-APR-2022 08:30, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # U008181, expiration date: 08-FEB-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 10 degree Celsius up to 8 degree Celsius (2.20 C (also reported as the max temperature reached to 2.20 C) for a time frame of 1 hour and 15 minutes. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2191248

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
22.03.2022
Impfdatum
19.02.2022
Beginn
19.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

An improperly stored dose of VARIVAX was administered to the patient on 19 FEB 2022; This spontaneous report has been received from a medical assistant referring to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant medications, previous drug reactions or allergies and concurrent conditions were not reported. On 19-FEB-2022, the patient was vaccinated with an improperly store dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliters (ml) (route of administration, anatomical site of vaccination, and vaccine scheme were not reported; lot number U008181 has been verified to be valid, expiration date reported and established as 08-FEB-2023) as prophylaxis. The vaccine was exposed to a temperature excursion of 9 degrees Fahrenheit (F) during a time frame of 293 hours and 14 minutes (product storage error). No previous temperature excursion was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA008282: US-009507513-2202USA007938: US-009507513-2202USA008270:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2174724

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
12.03.2022
Impfdatum
15.02.2022
Beginn
15.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

improperly stored dose of V ARlV AX was administered to the patient on 15 FEB 2022; This spontaneous report has been received from a medical assistant referring to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies were not reported. On 15-FEB-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliters (ml) (route of administration, anatomical site of vaccination and vaccine scheme were not reported; lot number U008181 has been verified to be valid, expiration date reported and established as 08-FEB-2023) as prophylaxis. The vaccine was exposed to a temperature excursion of 9 degrees Fahrenheit (F) during a time frame of 293 hours and 14 minutes (product storage error). There was no previous temperature excursion. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA008282: US-009507513-2202USA008270: US-009507513-2202USA007865:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2061569

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
25.01.2022
Impfdatum
11.01.2022
Beginn
11.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; Vaccines were administered after a temperature excursion; Information has been received from a vaccine coordinator, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 11-JAN-2022, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) orally (lot number and expiration date were not reported) or was vaccinated with an improperly dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U008181, expiration date 08-FEB-2023 (anatomical location and administration route were not reported) both vaccines for prophylaxis. No adverse effects were reported. The vaccines had temperature excursions of 14 Fahrenheit degrees (F) 39,6 F, during a time frame of 30 hours 15 minutes and 0 hours 45 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1951559

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U008181

gering
Staat
FL
Alter
30,0
Geschlecht
F
Eingang
15.12.2021
Impfdatum
06.12.2021
Beginn
15.12.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy

Symptomtext

Patient was given vaccine while pregnant in first trimester.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
n/a
Allergien
N/a
Vorherige Impfungen
-